Guangdong Hybribio Biotech Co Ltd operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Guangdong Hybribio Biotech Co Ltd with three other
companies in this sector in China:
Beijing Leadman Biochemistry Co Ltd
sales of 575.98 million Chinese Renmimbi [US$83.72 million]
of which 100%
was Biological products industry),
(302.89 million Chinese Renmimbi [US$44.02 million]
of which 94%
was Reagent Income), and
Getein Biotech Inc
(488.58 million Chinese Renmimbi [US$71.02 million]
of which 99%
was In-vitro diagnostics).